|
PDCD7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.317800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.503200E-03 |
| Normal-vs-Stage2 |
9.041000E-01 |
| Normal-vs-Stage3 |
6.332600E-01 |
| Normal-vs-Stage4 |
4.097000E-01 |
| Stage1-vs-Stage2 |
3.578200E-02 |
| Stage1-vs-Stage3 |
1.806630E-04 |
| Stage1-vs-Stage4 |
7.152400E-02 |
| Stage2-vs-Stage3 |
6.364000E-01 |
| Stage2-vs-Stage4 |
5.948200E-01 |
| Stage3-vs-Stage4 |
1.712560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.311630E-01 |
| Normal-vs-AfricanAmerican |
1.074430E-01 |
| Normal-vs-Asian |
4.720600E-01 |
| Caucasian-vs-AfricanAmerican |
3.758200E-01 |
| Caucasian-vs-Asian |
8.529200E-01 |
| AfricanAmerican-vs-Asian |
8.480400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.559400E-01 |
| Normal-vs-Female |
2.337600E-03 |
| Male-vs-Female |
2.139300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.469000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.413900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.647000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.183000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.881000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.527200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.273400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.382160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.170600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.954400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.233860E-02 |
| Normal-vs-Grade 2 |
4.756800E-03 |
| Normal-vs-Grade 3 |
9.510800E-01 |
| Normal-vs-Grade 4 |
6.609400E-01 |
| Grade 1-vs-Grade 2 |
5.321800E-02 |
| Grade 1-vs-Grade 3 |
1.268050E-02 |
| Grade 1-vs-Grade 4 |
1.667910E-02 |
| Grade 2-vs-Grade 3 |
6.561500E-04 |
| Grade 2-vs-Grade 4 |
4.024100E-02 |
| Grade 3-vs-Grade 4 |
6.659200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.501000E-03 |
| Normal-vs-ccB subtype |
8.659200E-01 |
| ccA subtype-vs-ccB subtype |
1.096250E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.785820E-01 |
| Normal-vs-N1 |
5.872600E-01 |
| N0-vs-N1 |
2.849400E-01 |
|
|
